Bristol Myers Squibb (BMY)
(Delayed Data from NYSE)
$44.23 USD
+0.92 (2.12%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $44.29 +0.06 (0.14%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth D Momentum C VGM
Fundamental Charts
About Dividend Yield (TTM)
For Bristol Myers Squibb Company, the company has a dividend yield of 5.73% compared to the Medical - Biomedical and Genetics industry's median yield of zero percent.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
BMY 44.23 +0.92(2.12%)
Will BMY be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BMY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BMY
Economy Heating Up on PCE for June
Bristol Myers Beats on Q2 Earnings and Sales, Raises '25 Sales View
BMY: What are Zacks experts saying now?
Zacks Private Portfolio Services
PCE Comes in Warmer Than Expected
Bristol Myers (BMY) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Bristol Myers Squibb (BMY) Q2 Earnings and Revenues Top Estimates
Other News for BMY
Earnings Scorecard: 18 out of 21 healthcare firms beat earnings forecast this week
Notable healthcare headlines for the week: Trump’s ultimatum to big pharma, Novo Nordisk, UnitedHealth and Moderna in focus
Bristol Myers (BMY) Price Target Reduced by Bernstein After Q2 Report
Bristol Myers price target lowered by $4 at Bernstein, here's why
Bristol-Myers Squibb: Declines Have Gone Too Far